Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo-Reference-Cited by-同舟云学术

Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Dobson Claire L.,Devine Paul W. A.,Phillips Jonathan J.,Higazi Daniel R.,Lloyd Christopher,Popovic Bojana,Arnold Joanne,Buchanan Andrew,Lewis Arthur,Goodman Joanne,van der Walle Christopher F.,Thornton Peter,Vinall Lisa,Lowne David,Aagaard Anna,Olsson Lise-Lotte,Ridderstad Wollberg Anna,Welsh Fraser,Karamanos Theodoros K.,Pashley Clare L.,Iadanza Matthew G.,Ranson Neil A.,Ashcroft Alison E.,Kippen Alistair D.,Vaughan Tristan J.,Radford Sheena E.,Lowe David C.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep38644.pdf

Reference54 articles.

1. Reichert, J. M. Antibodies to watch in 2016. MAbs 8, 197–204 (2016).

2. Vugmeyster, Y. et al. Complex pharmacokinetics of a humanized antibody against human amyloid beta peptide, anti-abeta Ab2, in nonclinical species. Pharm. Res. 28, 1696–1706 (2011).

3. Wu, H. et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J. Mol. Biol. 368, 652–665 (2007).

4. Deng, R. et al. Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned? MAbs 3, 61–66 (2011).

5. Hotzel, I. et al. A strategy for risk mitigation of antibodies with fast clearance. MAbs 4, 753–760 (2012).

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging Multi-Modal Feature Learning for Predictions of Antibody Viscosity;2024-09-01

2. Characterization of mAbs against Klebsiella pneumoniae type 3 fimbriae isolated in a target-independent phage display campaign;Microbiology Spectrum;2024-08-06

3. Elucidation of the Reversible Self-Association Interface of a Diabody–Interleukin Fusion Protein Using Hydrogen-Exchange Mass Spectrometry and In Silico Modeling;Molecular Pharmaceutics;2024-06-26

4. Toward enhancement of antibody thermostability and affinity by computational design in the absence of antigen;mAbs;2024-06-20

5. Phage display technology and its impact in the discovery of novel protein-based drugs;Expert Opinion on Drug Discovery;2024-06-18